| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $14.0M | -8.4% |
| SG&A Expense | $10.9M | +16.8% |
| Operating Income | -$24.8M | -1.2% |
| Pre-tax Income | -$24.3M | +0.7% |
| Net Income | -$24.3M | +0.7% |
| EPS (Basic) | -$0.66 | +2.9% |
| EPS (Diluted) | -$0.66 | +2.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $772K | -95.9% |
| Short-term Investments | $2.2M | -31.7% |
| Current Assets | $3.1M | -86.7% |
| Total Assets | $8.5M | -71.1% |
| Current Liabilities | $8.8M | +39.3% |
| Total Liabilities | $11.5M | +15.4% |
| Stockholders' Equity | -$3.0M | -115.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$19.3M | +26.4% |
| Capital Expenditures | $29K | -91.2% |
| Investing Cash Flow | $998K | +209.0% |
| Financing Cash Flow | $238K | -96.6% |
| Free Cash Flow | -$19.3M | +27.2% |